PENSACOLA, Florida — Scott Robinson, a 51-year-old from Pace, Florida, has pleaded guilty to two counts of drug adulteration in federal court.
The plea was announced by John P. Heekin, United States Attorney for the Northern District of Florida. “Complying with federal laws that are in place to ensure the safety of regulated medications is not optional. This defendant knowingly flouted those requirements for several years, but thanks to the excellent investigative work of our federal law enforcement partners, his scheme has been dismantled,” Heekin stated.
Court documents reveal that from 2022 to 2025, Robinson advertised and sold the animal drug toltrazuril via his website to customers across the United States. Under the Federal Food, Drug, and Cosmetic Act, toltrazuril is considered an adulterated new animal drug, subject to specific production, labeling, and sale requirements. The Federal Bureau of Investigation conducted multiple purchases of items labeled and advertised as toltrazuril from Robinson’s website. These items were tested by the Food and Drug Administration (FDA) and confirmed to contain toltrazuril. Robinson did not comply with FDA regulations regarding the production, labeling, and sale of toltrazuril…